Indefinite Delivery Contract SPE2DX16D1915

The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Under this contract, the DLA issues numerous delivery orders for various medications, including specialty drugs, brand-name and generic pharmaceuticals, as well as critical care materials such as syringes, vials, and test kits. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.

The delivery orders issued under the DLA Troop Support Medical IDC cover a wide variety of pharmaceutical and medical commodities, such as sodium chloride injection, aspirin tablets, fluticasone propionate, sumatriptan succinate, albendazole tablets, lidocaine patches, acetaminophen injections, and amoxicillin/clavulanic acid. These products are supplied to military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. The contract awards do not utilize any set-aside designations and are made on a firm fixed-price basis, with the place of performance located in Conshohocken, Pennsylvania. The delivery order values range from small amounts for common over-the-counter medications to larger sums for specialty pharmaceuticals, reflecting the diverse medical needs of the government agencies served under this IDC.